Postdischarge prophylaxis for venous thromboembolism among high-risk surgery patients

Abstract

The role of pharmacological prophylaxis against venous thromboembolism in high-risk surgical patients is straightforward during hospitalization but controversial after hospital discharge. Clinical trials based upon venography-detected deep vein thrombosis (DVT), yield high DVT rates which may not be clinically relevant, since most cases are asymptomatic. On the other hand, clinical surveys based upon clinically overt venous thromboembolism yield low DVT rates that underestimate the problem. If postdischarge prophylaxis is used, oral anticoagulants may be more cost-effective than low-molecular-weight heparins. However, optimal strategies for venous thromboembolism prophylaxis after hospital discharge will not be definitively provided until large studies are performed with sufficient power to detect clinically relevant endpoints such as symptomatic DVT or pulmonary embolism.

Keywords

deep vein thrombosis heparin low-molecular-weight heparins pulmonary embolism venography venous thromboembolism

References

Salzman EW , Hirsh J. The epidemiology, pathogenesis and natural history of venous thrombosis. In: Colman RW , Hirsh J , Marder VJ , Salzman EW eds. Haemostasis and thrombosis. Basic principles and clinical practice. Philadelphia, PA: JB Lippincott Company, 1994: 1275-1296.

Collins R , Scrimigeour A , Yusuf S , Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopaedic and urologic surgery. N Engl J Med 1988; 318: 1162-1173.

Gallus AS , Salzman EW , Hirsh J. Prevention of venous thromboembolism. In: Colman RW , Hirsh J , Marder VJ , Salzman EW eds. Haemostasis and thrombosis. Basic principles and clinical practice. Philadelphia, PA: JB Lippincott Company, 1994: 1331-1345.

Bergqvist D. Long-term prophylaxis following orthopedic surgery. Haemostasis 1993; 23: 27-31.

Sevitt S , Gallagher NG. Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet 1959; ii: 981-989.

Clarke-Pearson DL , Jelovsek FR , Creasman WT. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis. Obstet Gynecol 1983; 61: 87-94.

Clarke-Pearson DL , Synan IS , Coleman RE , Hinshaw W , Creasman WT. The natural history of postoperative venous thromboembolism in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol 1984; 148: 1051-1054.

Scurr JH , Coleridge Smith PD , Hasty JH. Deep venous thrombosis: a continuing problem. Br Med J 1988; 297: 28-28.

Hoek JA , Nurmohamed MT , Hamelynck KJ et al. Prevention of DVT following total hip replacement by low molecular weight heparinoid. Thromb Haemost 1992; 67: 28-32.

10.

Eriksson B , Zachrisson B , Teger-Nilsson AG , Risberg B. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg 1988; 75: 1053-1057.

11.

Huber O , Bounameaux H , Borst F , Rohner A. Postoperative embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127: 310-313.

12.

Amstutz HC , Frisene DA , Dorey F , Carmey BT. Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement. J Bone Joint Surg 1989; 71A: 742-747.

13.

Seagroatt V , Tan HS , Goldacre M , Bulatrode C , Nugent I , Gill L. Elective total hip replacement: incidence, emergency readmission rate and postoperative mortality. Br Med J 1991; 303: 1431-1435.

14.

Tremaine MD , Choroszy CJ , Menking SA. Deep vein thrombosis in the total hip arthroplasty patient after hospital discharge. J Vasc Technology 1991; 15: 205-206.

15.

Warwick D , Williams MH , Bannister GC. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg 1995; 77-B: 6-10.

16.

Warkentin TE , Levine MN , Hirsh J et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New Engl J Med 1995; 332: 1330-1335.

17.

Agnelli G , Radicchia S , Nenci GG. The diagnosis of DVT in asymptomatic high risk patients. Haemostasis 1995; 25: 40-48.

18.

Planes A , Vochelle N , Darmon JY , Fagola M , Bellaud M , Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-228.

19.

Bergqvist D , Benoni G , Björgell O et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 696-700.

20.

Dahl OE , Andreassen G , Aspelin T et al. Prolonged thromboprophyl-axis following hip replacement surgery-results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin®). Thromb Haemost 1997; 77: 26-31.

21.

Agnelli G , Ranucci V , Veschi F , Rinonapoli E , Lupattelli L , Nenci GG. Clinical outcome of hip surgery patients with negative lower limb venography at discharge. Thromb Haemost 1995; 74: 1042-1044.

22.

Ricotta S , Iorio A , Parise P , Nenci GG , Agnelli G. Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography. An overview analysis. Thromb Haemost 1996; 76: 887-892.

23.

Harris WH , Salzman EW , Athanasoulis C , Waltman AC , Baum S , DeSanctis RW. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg 1974; 56: 1552-1562.

24.

Eriksson BI , Kalebo P , Anthmyr A , Wadenvik H , Tengborn L , Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg 1991; 73: 484-493.

25.

Bergqvist D , Kettunen K , Fredin H et al. Thromboprophylaxis in patients with hip fractures: a prospective, randomized, comparative study between Org 10172 and dextran 70. Surgery 1991; 109: 617-622.

26.

Hoek JA , Nurmohamed MT , Hamelynck KJ et al. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost 1992; 67: 28-32.

27.

Leclerc JR , Geerts WH , Desjardins L et al. Prevention of deep vein thrombosis after major knee surgery. A randomized, double blind trial comparing a low molecular weight heparin fragment (Enoxaparin) to placebo. Thromb Haemost 1992; 67: 417-423.

28.

The German Hip Arthroplasty Trial (GHAT) Group . Prevention of deep vein thrombosis with low molecular weight heparin in patients undergoing total hip replacement. A randomized trial. Arch Orthop Surg 1992; 111: 110-120.

29.

Agnelli G , Cosmi B , Di Filippo P et al. A randomised, double-blind, placebo-controlled trial of deramtan sulfate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost 1992; 67: 203-208.

30.

Hull R , Raskob G , Pineo G et al. A comparison of subcutaneous low molecular weight heparin with warfarin sodium for prophylaxis against deep vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-1375.

31.

Fauno P , Suomalainen O , Rehnberg V et al. Thromboembolic prophy-laxis in total knee replacement patients. An evaluation of two different regimens. Thromb Haemost 1993; 69: 1055-1055.

32.

Cohen AT , Phillips MJ , Edmondson RA et al. A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty. Thromb Haemost 1994; 73: 793-798.

33.

Spiro TE , Johnson GJ , Christie MJ et al. Efficacy and safety of Enoxaparin to prevent deep vein thrombosis after hip replacement surgery. Ann Intern Med 1994; 121: 81-89.

34.

Trowbridge A , Boese CK , Woodruff B , Brindley HH , Lowry WE , Spiro TE. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty. Clin Orthop Rel Res 1994; 299: 203-208.

35.

Agnelli G , Damiani M , Veschi F et al. A double blind randomised trial on Organon versus unfractionated heparin in the prevention of deep vein thrombosis after elective hip replacement. Thromb Haemost 1995; 73: 1103-1103.

36.

Sarasin FP , Bounameaux H. Cost-effectiveness of prophylactic anticoagulation prolonged after hospital discharge following general surgery. Arch Surg 1996; 131: 694-697.

37.

Sarasin FP , Bounameaux H. Antithrombotic strategy after total hip replacement. Arch Intern Med 1996; 156: 1661-1668.

38.

Robinson KS , Anderson DR , Gross M et al. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized controlled trial. Ann Intern Med 1997; 127: 439-445.